[Refractory hypertension].

I Os; I K Eide; A S Westheim; S E Kjeldsen

Home/Archive/PubMed

PubMed · 7900136

[Refractory hypertension].

I Os·I K Eide·A S Westheim·S E Kjeldsen

View original source ↗Export metadata ↓

Abstract

Resistant hypertension is a common disorder in general practice, and poses a challenge to clinicians. It is generally defined as failure to reduce blood pressure adequately despite the use of at least three different antihypertensive agents with different modes of action. The importance of recognizing expansion of plasma volume as a mediator of resistance to therapy is emphasized. Some patients may have white-coat hypertension. An even larger group of patients may fail to comply with the prescribed medication. A good physician-patient relationship is vital, and education of the patient is crucial for obtaining better adherence to the medication.

Explore related subjects

Antihypertensive Agents Drug Resistance Humans Hypertension Patient Compliance Physician-Patient Relations English Abstract Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

I Os, I K Eide, A S Westheim, S E Kjeldsen. 1995-02-28. [Refractory hypertension].. https://pubmed.ncbi.nlm.nih.gov/7900136/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Detection of renal artery stenosis with Doppler sonography before and after administration of captopril: value of early systolic rise.

OBJECTIVE: The goal of this study was to assess the value of quantitative and qualitative analysis of the early systolic rise on Doppler waveforms obtained before and after administration of captopril in patients suspected of having renal artery stenosis. SUBJECTS AND METHODS: Seventy-one hypertensive patients (135 kidneys) were studied with transrenal Doppler sonography. Ninety-six kidneys were studied again after administration of captopril. All patients also underwent renal angiography. All Doppler studies were independently reviewed by two observers. Specific criteria for Doppler waveform patterns that were applied in the detection of renal artery stenosis included acceleration, acceleration time of early systolic rise, differential velocity of systolic rise, and resistive index. These criteria were then correlated with angiography, and receiver operating characteristic curves were generated. RESULTS: On the basis of waveform pattern recognition. Doppler sonograms obtained before administration of captopril had a sensitivity of 81% and a specificity of 98% for the detection of renal artery stenosis greater than or equal to 50%. Sensitivity of Doppler sonography obtained after administration of captopril was 100%, and specificity was 100%. For renal artery stenosis greater than or equal to 70%, sensitivity was 94% and specificity was 89% before administration of captopril. The area under the receiver operating characteristic curve for the acceleration criterion was significantly larger after administration of captopril (p = .009) for the detection of renal artery stenosis greater than or equal to 50%. After captopril administration, an acceleration threshold value of 440 cm/sec2 for early systolic rise was associated with a sensitivity of 100% and a specificity of 94% for the detection of renal artery stenosis greater than or equal to 50%. CONCLUSION: Doppler sonography of the renal arteries performed before administration of captopril appears to be an excellent screening tool in the detection of severe stenosis (> or = 70%). Administration of captopril improves the detection of renal artery stenosis greater than or equal to 50% with Doppler sonography when observers use both morphologic and quantitative criteria.

Antihypertensive Agents↗

PubMed1997

An imputation method for non-ignorable missing data in studies of blood pressure.

In studies with repeated measures of blood pressure (BP), particularly in trials of hypertension prevention, BP measurements often become censored once a participant commences antihypertensive medication. When prescribed by non-study physicians under uncontrolled conditions, the missing data mechanism is non-ignorable and may bias the BP effects of interest. I propose a method that models the distribution of BPs measured by non-study physicians and their relation to study BPs using random effects models. If treated for hypertension, I assume that BP measured outside the study is greater than a clinical cutpoint, such as diastolic BP > or = 90 mmHg. I then compute estimates for the missing study BPs conditional on previously observed study BPs and treatment for hypertension. Multiple imputation is used to model the variability of the BP values and adjust the standard error estimates of the parameters. Examples are given using simulated data and data from the weight loss intervention of phase I of the Trials of Hypertension Prevention.

Antihypertensive Agents↗

PubMed1997

Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.

CONTEXT: The choice of pharmacological treatment for the approximately 50 million people in the United States with hypertension has important therapeutic and financial implications. OBJECTIVES: To describe national antihypertensive medication prescribing patterns for 1992 and 1995; to explore the influence of the Fifth Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V), published in 1993, which recommended diuretics and beta-blockers as first-line antihypertensive therapy unless contraindicated; and to estimate the impact of these prescribing patterns on the cost of antihypertensive treatment. DESIGN: All prescriptions for drugs approved for the treatment of hypertension dispensed by 35000 retail pharmacies were tabulated for 1992 and 1995 (62% of all US retail pharmacies were surveyed). MAIN OUTCOME MEASURES: Number of prescriptions for each dosage form of medication and national cost estimates based on wholesale costs of medications dispensed. RESULTS: In 1992, of the 10 most frequently prescribed antihypertensive drugs, 3 were calcium antagonists, 3 were angiotensin-converting enzyme (ACE) inhibitors, 3 were beta-blockers, and 1 was the combination of triamterene and hydrochlorothiazide. In 1995, 4 were calcium antagonists, 3 were ACE inhibitors, 1 was a beta-blocker, 1 was the combination of triamterene and hydrochlorothiazide, and 1 an alpha-blocker. In 1992, calcium antagonists accounted for 33% of antihypertensive prescriptions compared with 38% in 1995, ACE inhibitor use went from 25% to 33%, beta-blocker use from 18% to 11%, and diuretic use from 16% to 8%. The estimated wholesale costs for calcium antagonists in 1995 dollars increased from $2.67 billion in 1992 to $2.86 billion in 1995; ACE inhibitor costs increased from $1.37 billion to $1.67 billion; costs for diuretics declined from $353 million to $168 million; and costs for beta-blockers declined from $763 million to $433 million. CONCLUSIONS: From 1992 to 1995 use of calcium antagonists and ACE inhibitors for treatment of hypertension increased and diuretics and beta-blockers declined, suggesting that the recommendations from JNC V had little effect on prescribing patterns. The cost implications of these practice patterns are enormous.

Antihypertensive Agents↗